GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » EV-to-FCF

RIV Capital (XCNQ:RIV) EV-to-FCF : -2.49 (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RIV Capital's Enterprise Value is C$101.07 Mil. RIV Capital's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was C$-40.51 Mil. Therefore, RIV Capital's EV-to-FCF for today is -2.49.

The historical rank and industry rank for RIV Capital's EV-to-FCF or its related term are showing as below:

XCNQ:RIV' s EV-to-FCF Range Over the Past 10 Years
Min: -224.53   Med: -1.4   Max: 1190.14
Current: -2.49

During the past 5 years, the highest EV-to-FCF of RIV Capital was 1190.14. The lowest was -224.53. And the median was -1.40.

XCNQ:RIV's EV-to-FCF is ranked worse than
100% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23 vs XCNQ:RIV: -2.49

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), RIV Capital's stock price is C$0.145. RIV Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.685. Therefore, RIV Capital's PE Ratio for today is At Loss.


RIV Capital EV-to-FCF Historical Data

The historical data trend for RIV Capital's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital EV-to-FCF Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-FCF
- -227.16 -16.56 -25.27 -2.71

RIV Capital Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -1.25 -1.60 -0.28 -2.29

Competitive Comparison of RIV Capital's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where RIV Capital's EV-to-FCF falls into.



RIV Capital EV-to-FCF Calculation

RIV Capital's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=101.070/-40.51
=-2.49

RIV Capital's current Enterprise Value is C$101.07 Mil.
RIV Capital's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-40.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RIV Capital  (XCNQ:RIV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

RIV Capital's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.145/-0.685
=At Loss

RIV Capital's share price for today is C$0.145.
RIV Capital's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.685.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


RIV Capital EV-to-FCF Related Terms

Thank you for viewing the detailed overview of RIV Capital's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.
Executives
Richard P. Mavrinac Director
Edward James Cirillo Lucarelli Senior Officer